Bile Duct Cancer Market Top Players Business Value Stated US$ 429.6 Million, at a CAGR of 12.8% By 2028: Agios Pharmaceuticals, Inc., RenovoRx, Ability Pharmaceuticals, Imbrium Therapeutics L.P.

May 23rd, 2022 Releases

“๐ˆ๐ง ๐ญ๐จ๐๐š๐ฒ’๐ฌ ๐œ๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐ข๐ฏ๐ž ๐ฆ๐š๐ซ๐ค๐ž๐ญ, ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐š๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐ข๐ฌ ๐š ๐œ๐ซ๐ข๐ญ๐ข๐œ๐š๐ฅ ๐ฌ๐ญ๐ž๐ฉ ๐ข๐ง ๐ข๐๐ž๐ง๐ญ๐ข๐Ÿ๐ฒ๐ข๐ง๐  ๐ญ๐ก๐ž ๐œ๐จ๐ซ๐ซ๐ž๐œ๐ญ ๐ญ๐š๐ซ๐ ๐ž๐ญ ๐œ๐จ๐ง๐ฌ๐ฎ๐ฆ๐ž๐ซ๐ฌ ๐š๐ง๐ ๐ฉ๐ซ๐จ๐ฏ๐ข๐๐ข๐ง๐  ๐œ๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ฌ๐ž๐ ๐ฌ๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง๐ฌ ๐Ÿ๐จ๐ซ ๐ญ๐ก๐ž๐ข๐ซ ๐›๐ฎ๐ฌ๐ข๐ง๐ž๐ฌ๐ฌ ๐ง๐ž๐ž๐๐ฌ. ๐–๐ก๐ข๐ฅ๐ž ๐Ÿ๐จ๐ซ๐ฆ๐ฎ๐ฅ๐š๐ญ๐ข๐ง๐  ๐ญ๐ก๐ž๐ฌ๐ž ๐ฌ๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง๐ฌ, ๐ž๐ฏ๐ž๐ซ๐ฒ ๐Ÿ๐š๐œ๐ž๐ญ ๐š๐ง๐ ๐ฌ๐ฉ๐ž๐œ๐ข๐Ÿ๐ข๐œ ๐ฉ๐ซ๐จ๐›๐ฅ๐ž๐ฆ ๐ฉ๐ซ๐ž๐ฌ๐ž๐ง๐ญ๐ž๐ ๐›๐ฒ ๐ญ๐ก๐ž ๐ฉ๐š๐ซ๐ญ๐ข๐œ๐ฎ๐ฅ๐š๐ซ ๐ฌ๐ž๐œ๐ญ๐จ๐ซ ๐ข๐ฌ ๐ญ๐ก๐จ๐ซ๐จ๐ฎ๐ ๐ก๐ฅ๐ฒ ๐œ๐จ๐ง๐ฌ๐ข๐๐ž๐ซ๐ž๐. ๐ˆ๐ญ ๐š๐ฅ๐ฌ๐จ ๐œ๐จ๐ง๐ฌ๐ข๐๐ž๐ซ๐ฌ ๐ง๐ฎ๐ฆ๐ž๐ซ๐จ๐ฎ๐ฌ ๐ ๐จ๐ฏ๐ž๐ซ๐ง๐ฆ๐ž๐ง๐ญ ๐ซ๐ž๐Ÿ๐จ๐ซ๐ฆ๐ฌ, ๐ญ๐ก๐ž ๐œ๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐ข๐ฏ๐ž ๐ž๐ง๐ฏ๐ข๐ซ๐จ๐ง๐ฆ๐ž๐ง๐ญ, ๐œ๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ž๐ซ ๐›๐ž๐ก๐š๐ฏ๐ข๐จ๐ฎ๐ซ, ๐œ๐ฎ๐ซ๐ซ๐ž๐ง๐ญ ๐š๐ง๐ ๐Ÿ๐ฎ๐ญ๐ฎ๐ซ๐ž ๐›๐ฎ๐ฌ๐ข๐ง๐ž๐ฌ๐ฌ ๐ฌ๐ญ๐ซ๐š๐ญ๐ž๐ ๐ข๐ž๐ฌ, ๐š๐ง๐ ๐ซ๐š๐ฉ๐ข๐๐ฅ๐ฒ ๐œ๐ก๐š๐ง๐ ๐ข๐ง๐  ๐ญ๐ž๐œ๐ก๐ง๐ข๐œ๐š๐ฅ ๐›๐ซ๐ž๐š๐ค๐ญ๐ก๐ซ๐จ๐ฎ๐ ๐ก๐ฌ. ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐š๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐š๐ข๐๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐Ÿ๐จ๐ซ๐ฆ๐ฎ๐ฅ๐š๐ญ๐ข๐จ๐ง ๐จ๐Ÿ ๐›๐ฎ๐ฌ๐ข๐ง๐ž๐ฌ๐ฌ ๐ฉ๐ฅ๐š๐ง๐ฌ ๐š๐ง๐ ๐ฉ๐จ๐ฅ๐ข๐œ๐ข๐ž๐ฌ.”

The global bile duct cancer market is estimated to be valued at US$ 185.4 million in 2021 and is expected to exhibit a CAGR of 12.8% over the forecast period (2021-2028).

Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/4790

Global Bile Duct Cancer Market: Drivers

R&D of new drugs is expected to propel growth of the global bile duct cancer market over the forecast period. For instance, Leap therapeutics, in 2015, reported development of DKN-01, a humanized monoclonal antibody. It is under clinical trial phase I for treatment of bile duct cancer through its anti-neoplastic activity.

Global Bile Duct Cancer Market: Opportunitiesย 

R&D of new drugs is expected to offer lucrative growth opportunities for players in the global bile duct cancer market over the forecast period. For instance, Merck Sharp & Dohme Corp, in September 2019, started a clinical trial to assess the efficacy of Pembrolizumab (immunotherapy) in combination with Gemcitabine/Cisplatin for the treatment of bile duct cancer.

Global Bile Duct Cancer Market: Restraintsย 

Growth of the global bile duct cancer market is limited due to high cost associated with the treatment of bile duct cancer. For example, the total cost of treatment for bile duct cancer increased from US$ 36,460 in 1997 to US$ 77,753 in 2012, according to the U.S. National Library of Medicine report 2017. Moreover, cancer treatment (including chemotherapy, targeted therapy, and others) related costs in the U.K. are approximately 0.1 to 0.15% of GDP or accounts 20 to 25% for oncology treatments, according to the data published in UCL School of Pharmacy report 2020.

Request Here PDF Brochure Of This Report @ https://www.coherentmarketinsights.com/insight/request-pdf/4790

Global Bile Duct Cancer Market: Competitive Landscape

Major players operating in the global bile duct cancer market include, Ability Pharmaceuticals, Agios Pharmaceuticals, Inc., Delcath Systems, Inc., Eisai Co., Ltd., Imbrium Therapeutics L.P., Incyte Corporation, QED Therapeutics, Inc., and RenovoRx.

Global Bile Duct Cancer Market: Key Developmentsย 

Major players operating in the global bile duct cancer market are focused on adopting partnership and collaboration strategies to expand their product portfolio. For instance, QED Therapeutics, in Mach 2021, collaborated with Helsinn Group to co-develop and commercialize Infigratinib, an oral FGFR1-3 selective inhibitor, for patients dealing with bile duct cancer.

Global Bile Duct Cancer Market: Segmentationย 

By Treatment Type:

  • Chemotherapy
    • Gemcitabine
    • Cisplatin
    • Oxaliplatin
    • Capecitabine
    • 5 fluorouracil (5-FU)
  • Targeted Therapy
    • Pemigatinib
    • Infigratinib (Phase 3)
    • Ivosidenib (Phase 3)
  • Immunotherapy
    • Pembrolizumab (Phase 3)
    • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Buy This Research Study Report With Flat USD 2000 OFF @ https://www.coherentmarketinsights.com/promo/buynow/4790

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Treatment Type
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Drivers
    • Restraints
    • Opportunity
    • Impact Analysis
    • Pipeline Analysis
    • Regulatory Scenario
    • Market Trends
    • Key Developments
    • Epidemiology
    • PEST Analysis
    • Brand Analysis
  4. Global Bile Duct Cancer market โ€“ Impact of Coronavirus (Covid-19) Pandemic
    • Economic Impact
    • COVID-19 Epidemiology
    • Impact on Clinical Trials and Drug Development
    • Government Initiatives
  5. Global Bile Duct Cancer market, By Treatment Type, 2021 โ€“ 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 โ€“ 2028
      • Segment Trends
    • Chemotherapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 โ€“ 2028, (US$ Mn)
        • Gemcitabine
        • Cisplatin
        • Oxaliplatin
        • Oxaliplatin
        • 5 fluorouracil (5-FU)
    • Targeted Therapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 โ€“ 2028, (US$ Mn)
        • Pemigatinib
        • Infigratinib (Phase 3)
        • Ivosidenib (Phase 3)
    • Immunotherapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 โ€“ 2028, (US$ Mn)
        • Pembrolizumab (Phase 3)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 โ€“ 2028, (US$ Mn)
  6. Global Bile Duct Cancer market, By Distribution Channel, 2021 โ€“ 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 โ€“ 2028
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 โ€“ 2028, (US$ Mn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 โ€“ 2028, (US$ Mn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 โ€“ 2028, (US$ Mn)
  7. Global Bile Duct Cancer market, By Region, 2021 โ€“ 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, For Regions, 2018โ€“2028
    • North America
      • Market Size and Forecast, By Treatment Type, 2021 โ€“ 2028, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 โ€“ 2028, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 โ€“ 2028, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Treatment Type, 2021 โ€“ 2028, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 โ€“ 2028, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 โ€“ 2028, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Treatment Type, 2021 โ€“ 2028, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 โ€“ 2028, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 โ€“ 2028, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Treatment Type, 2021 โ€“ 2028, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 โ€“ 2028, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 โ€“ 2028, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Treatment Type, 2021 โ€“ 2028, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 โ€“ 2028, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 โ€“ 2028, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Treatment Type, 2021 โ€“ 2028, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2021 โ€“ 2028, (US$ Mn)
      • Market Size and Forecast, By Region/Country, 2021 โ€“ 2028, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa

View Press Release: https://www.coherentmarketinsights.com/press-release/bile-duct-cancer-market-4050

About Us:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact Us:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

ยฉ Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.